
### [NCIT:C7359](http://purl.obolibrary.org/obo/NCIT_C7359)
**Label:** Endometrial Adenocarcinoma

**Subclasses:** [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C27838](http://purl.obolibrary.org/obo/NCIT_C27838) (Endometrial Serous Adenocarcinoma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287) (Endometrial Endometrioid Adenocarcinoma), [NCIT:C8028](http://purl.obolibrary.org/obo/NCIT_C8028) (Endometrial Clear Cell Adenocarcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40144](http://purl.obolibrary.org/obo/NCIT_C40144) (Endometrial Mucinous Adenocarcinoma), [NCIT:C40145](http://purl.obolibrary.org/obo/NCIT_C40145) (Type I Endometrial Adenocarcinoma), [NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma), [NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma), [NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma), [NCIT:C39749](http://purl.obolibrary.org/obo/NCIT_C39749) (Type II Endometrial Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 37.63%


